pharma · Advanced Solid Tumor · Advanced Solid Tumors
Multitude Therapeutics
Multitude Therapeutics is a pharma organization headquartered in CN. Primary therapeutic focus areas include Advanced Solid Tumor, Advanced Solid Tumors. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and
Redwood City, USA HQ
2018 Founded
9 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Redwood City, USA
- Founded
- 2018
- Employees
- 9
- Programs
- 2
- Drugs
- 0
- Patents
- 0
AMT-676
Phase 1 · small molecule · Advanced Solid Tumors
AMT-676 for Advanced Solid Tumors is a Phase 1 program (small_molecule) at Multitude Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code AMT-676-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Multitude Therapeutics
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Advanced Solid Tumors
- Status
- active
- Trials
- 1